Edesa Biotech Inc. Common Shares (EDSA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Edesa Biotech Inc. Common Shares (EDSA) is Neutral.

The composite score behind that read is -0.18, weighing +0.23 of bullish evidence against -0.33 bearish.

Edesa Biotech Inc. Common Shares last closed at $3.51, -4.10% on the session.

Against the IVW growth benchmark the position is -4.90% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for EDSA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Edesa Biotech Inc. Common Shares in the 2nd percentile on return on equity, where 100 is best.

Edesa Biotech Inc. Common Shares is classified under Health Care / Biotechnology, with a market capitalisation of $49.42M.

StockMap tracks Edesa Biotech Inc. Common Shares as the 313th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Edesa Biotech Inc. Common Shares ranks 298th of 381 in the group, against a group median of -0.08.